Angiotensin Receptor Blockers and Subclinical Interstitial Lung Disease: The MESA Study

Ann Am Thorac Soc. 2019 Nov;16(11):1451-1453. doi: 10.1513/AnnalsATS.201903-198RL.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angiotensin Receptor Antagonists / adverse effects
  • Angiotensin Receptor Antagonists / therapeutic use*
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Biomarkers / blood*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Lung Diseases, Interstitial / blood
  • Lung Diseases, Interstitial / diagnostic imaging
  • Lung Diseases, Interstitial / enzymology*
  • Male
  • Matrix Metalloproteinase 7 / blood
  • Middle Aged
  • Prospective Studies
  • Pulmonary Surfactant-Associated Protein A / blood
  • Tomography, X-Ray Computed

Substances

  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents
  • Biomarkers
  • Pulmonary Surfactant-Associated Protein A
  • MMP7 protein, human
  • Matrix Metalloproteinase 7